![Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenstrom Macroglobulinemia]()
Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenstrom MacroglobulinemiaKuiatse, I.; Baladandayuthapani, V.; Lin, H. Y.; Thomas, S. K.; Bjorklund, C. C.; Weber, D. M.; Wang, M.; Shah, J. J.; Zhang, X.-D.; Jones, R. J.; Ansell, S. M.; Yang, G.; Treon, S. P.; Orlowski, R. Z. · Clinical Cancer Research · 2015